Only half of people with multidrug resistant TB are cured, and patients run a high risk of losing their hearing due to the drugs.
Mia Malan is the founder and editor-in-chief of Bhekisisa. She has worked in newsrooms in Johannesburg, Nairobi and Washington, DC, winning more than 30 awards for her radio, print and television work.
